1. Cerebrovascular complications of cocaine use

   Newsletter Article 12 February 2013 Pages: 2 - 2

2. Drugs influencing carbamazepine serum levels

   Newsletter Article 12 February 2013 Pages: 2 - 3

3. Antineoplastics: interaction with calcium antagonists

   Newsletter Article 12 February 2013 Pages: 3 - 4

4. Adverse effects linked to cocaine use

   Newsletter Article 12 February 2013 Pages: 4 - 4

5. Alcohol dependence

   Newsletter Article 12 February 2013 Pages: 5 - 5

6. Alprazolam dependence

   Newsletter Article 12 February 2013 Pages: 5 - 5

7. Amiodarone

   Newsletter Article 12 February 2013 Pages: 5 - 5

8. Amobarbital

   Newsletter Article 12 February 2013 Pages: 5 - 5

9. Amsacrine

   Newsletter Article 12 February 2013 Pages: 5 - 5

10. Analgesics

    Newsletter Article 12 February 2013 Pages: 6 - 6

11. Anticoagulants

    Newsletter Article 12 February 2013 Pages: 6 - 6

12. Antimalarials

    Newsletter Article 12 February 2013 Pages: 6 - 6

13. Antipsychotics

    Newsletter Article 12 February 2013 Pages: 6 - 6

14. Aspirin

    Newsletter Article 12 February 2013 Pages: 6 - 6

15. Busulfan

    Newsletter Article 12 February 2013 Pages: 6 - 7

16. Cisplatin

    Newsletter Article 12 February 2013 Pages: 7 - 7

17. Clozapine

    Newsletter Article 12 February 2013 Pages: 7 - 7

18. Cocaine

    Newsletter Article 12 February 2013 Pages: 7 - 7

19. Cotrimoxazole

    Newsletter Article 12 February 2013 Pages: 7 - 8

20. Cyclosporin

    Newsletter Article 12 February 2013 Pages: 8 - 8

21. Diethylstilbestrol

    Newsletter Article 12 February 2013 Pages: 8 - 8

22. Dihydroergotamine interaction

    Newsletter Article 12 February 2013 Pages: 8 - 8

23. Diuretics

    Newsletter Article 12 February 2013 Pages: 8 - 8

24. Erythromycin

    Newsletter Article 12 February 2013 Pages: 8 - 8

25. Erythromycin see Dihydroergotamine interaction

    Newsletter Article 12 February 2013 Pages: 8 - 8

26. Fenbufen

    Newsletter Article 12 February 2013 Pages: 8 - 8

27. Fluphenazine

    Newsletter Article 12 February 2013 Pages: 8 - 9

28. Fusidic acid

    Newsletter Article 12 February 2013 Pages: 9 - 9

29. Gentamicin/tobramycin

    Newsletter Article 12 February 2013 Pages: 9 - 9

30. H2 antagonists

    Newsletter Article 12 February 2013 Pages: 9 - 9

31. Halothane see Theophylline interaction

    Newsletter Article 12 February 2013 Pages: 9 - 9

32. Heparin

    Newsletter Article 12 February 2013 Pages: 9 - 9

33. Indomethacin

    Newsletter Article 12 February 2013 Pages: 9 - 9

34. Insulin

    Newsletter Article 12 February 2013 Pages: 10 - 10

35. Isotretinoin

    Newsletter Article 12 February 2013 Pages: 10 - 10

36. Lidocaine

    Newsletter Article 12 February 2013 Pages: 10 - 10

37. Lithium

    Newsletter Article 12 February 2013 Pages: 10 - 10

38. Lithium overdose

    Newsletter Article 12 February 2013 Pages: 10 - 10

39. Metformin

    Newsletter Article 12 February 2013 Pages: 10 - 10

40. Methotrexate

    Newsletter Article 12 February 2013 Pages: 10 - 10

41. Mitoxantrone

    Newsletter Article 12 February 2013 Pages: 10 - 10

42. Nafcillin

    Newsletter Article 12 February 2013 Pages: 10 - 11

43. Peripheral vasodilators

    Newsletter Article 12 February 2013 Pages: 11 - 11

44. Phenelzine

    Newsletter Article 12 February 2013 Pages: 11 - 11

45. Phenytoin

    Newsletter Article 12 February 2013 Pages: 11 - 11

46. Plasminogen activator

    Newsletter Article 12 February 2013 Pages: 11 - 11

47. Propranolol

    Newsletter Article 12 February 2013 Pages: 11 - 11

48. Salbutamol see Theophylline interaction

    Newsletter Article 12 February 2013 Pages: 12 - 12

49. Theophylline interaction

    Newsletter Article 12 February 2013 Pages: 12 - 12

50. Tobramycin see Gentamicin/tobramycin

    Newsletter Article 12 February 2013 Pages: 12 - 12